Incyte Corporation (INCY) Stock Overview
Explore Incyte Corporation’s financial performance, market position, analyst ratings, and future outlook.
Incyte Corporation (INCY)
Key Financials
Key Financials
Market Cap
23B
P/E Ratio
13.93
EPS (TTM)
$7.44
ROE
0.30%
INCY Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Incyte Corporation (NASDAQ: INCY) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of A, Incyte Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of INCY on the NASDAQ shows an RSI of 43.12, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $127.94 for the NASDAQ listing.
Key metrics behind Incyte Corporation's NASDAQ-traded stock include a P/E ratio of 13.93 and a market capitalization of 23B. Combined with our AI analysis, these give both institutional and retail investors a clear view of INCY on the NASDAQ.